Add to ORKGFGFR2 point mutations in 466 endometrioid endometrial tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological feature
cancer Alterations in oncogenes are critical steps in the develop-ment of endometrial cancer. To inv...
Objective. Endometrial cancer patients may benefit from systemic adjuvant chemotherapy, alone or in ...
Endometriosis is a benign condition characterized by the presence of ectopic endometrial tissue. It ...
Mutations in multiple oncogenes including KRAS, CTNNB1, PIK3CA and FGFR2 have been identified in end...
<div><p>Mutations in multiple oncogenes including <em>KRAS</em>, <em>CTNNB1</em>, <em>PIK3CA</em> an...
<p>Blue diamonds indicate each instance of a mutation in the Washington University School of Medicin...
Endometrial carcinoma is the most common gynecological malignancy in the United States. Although mos...
Mutations in multiple oncogenes including KRAS, CTNNB1, PIK3CA and FGFR2 have been identified in end...
Purpose Activating FGFR2 mutations have been identified in ~ 10% of endometrioid endometrial cancers...
Background: Despite being the most common pelvic gynecologic malignancy in industrialized countries,...
Although molecularly targeted therapies have been effective in some cancer types, no targeted therap...
<div><h3>Background</h3><p>Despite being the most common pelvic gynecologic malignancy in industrial...
Background: Incidence of endometrial cancer is increasing in industrialised countries. Despite early...
Women diagnosed with early-stage (FIGO 1) endometrial cancer, grade 1 and 2 can have a good prognosi...
Endometrial carcinomas are histologically classified as endometrioid, assumed to originate from hype...
cancer Alterations in oncogenes are critical steps in the develop-ment of endometrial cancer. To inv...
Objective. Endometrial cancer patients may benefit from systemic adjuvant chemotherapy, alone or in ...
Endometriosis is a benign condition characterized by the presence of ectopic endometrial tissue. It ...
Mutations in multiple oncogenes including KRAS, CTNNB1, PIK3CA and FGFR2 have been identified in end...
<div><p>Mutations in multiple oncogenes including <em>KRAS</em>, <em>CTNNB1</em>, <em>PIK3CA</em> an...
<p>Blue diamonds indicate each instance of a mutation in the Washington University School of Medicin...
Endometrial carcinoma is the most common gynecological malignancy in the United States. Although mos...
Mutations in multiple oncogenes including KRAS, CTNNB1, PIK3CA and FGFR2 have been identified in end...
Purpose Activating FGFR2 mutations have been identified in ~ 10% of endometrioid endometrial cancers...
Background: Despite being the most common pelvic gynecologic malignancy in industrialized countries,...
Although molecularly targeted therapies have been effective in some cancer types, no targeted therap...
<div><h3>Background</h3><p>Despite being the most common pelvic gynecologic malignancy in industrial...
Background: Incidence of endometrial cancer is increasing in industrialised countries. Despite early...
Women diagnosed with early-stage (FIGO 1) endometrial cancer, grade 1 and 2 can have a good prognosi...
Endometrial carcinomas are histologically classified as endometrioid, assumed to originate from hype...
cancer Alterations in oncogenes are critical steps in the develop-ment of endometrial cancer. To inv...
Objective. Endometrial cancer patients may benefit from systemic adjuvant chemotherapy, alone or in ...
Endometriosis is a benign condition characterized by the presence of ectopic endometrial tissue. It ...